Koers Capha Pharmaceuticals Inc. Other OTC
Aandelen
FPSUF
CA13962W1086
Farmaceutische producten
Omzet 2021 | - | Omzet 2022 | - | Marktkapitalisatie | 8,87K 8,28K |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | - 0 | Nettowinst (verlies) 2022 | - 0 | EV/omzet 2021 | - |
Nettoschuld 2021 | 335K 312K | Nettoschuld 2022 | 415K 387K | EV/omzet 2022 | - |
K/w-verhouding 2021 |
-0,15
x | K/w-verhouding 2022 |
-0,12
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 33,36% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
James Brown
CEO | Chief Executive Officer | - | 31-10-02 |
Janice Brown
BRD | Director/Board Member | - | 01-11-02 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
James Brown
CEO | Chief Executive Officer | - | 31-10-02 |
Janice Brown
BRD | Director/Board Member | - | 01-11-02 |
Herbert Leary
BRD | Director/Board Member | - | 25-10-10 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+26,47% | 664 mld. | |
+25,70% | 567 mld. | |
-6,33% | 354 mld. | |
+19,35% | 330 mld. | |
+4,23% | 286 mld. | |
+13,42% | 234 mld. | |
+4,71% | 199 mld. | |
-10,10% | 196 mld. | |
-4,04% | 148 mld. |